Story C-3-(N-alkyl-aryl)-aminomethyl rifamycin SV derivatives exhibit activity towards rifampicin-resistant Mycobacterium tuberculosis RpoBS522L pressure as well as show an alternative presenting method on the RNAP β-subunit website in comparison with rifampicin.